DERM FINAL: other skin disorders and pigment disorders

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/86

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

87 Terms

1
New cards

population affected by hidradenitis suppurtiva

women of reproductive age (shortly after puberty)

2
New cards

cause of hidradenitis suppurtiva

-occlusion of hair follicle via hyperkeratosis

-TNF-alpha significantly increased

-hormones, comorbidities

3
New cards

manifestation of hidradenitis suppurtiva

-gradual onset, chronic flares

-persistent/recurrent boil-like lesions in axillae/inguinal area

-painful

-can progress to open "tombstone" comedones

4
New cards

hidradenitis suppurtiva diagnosis

hidradenitis suppurtiva

5
New cards

definitive hidradenitis suppurtiva diagnosis requires presence of 3 criteria:

typical lesion (1+)

typical distribution

chronic/recurrent sx

6
New cards

hidradenitis suppurtiva typical lesions

painful nodule

abscess

draining sinuses

double open comedones

bridged scars

7
New cards

hidradenitis suppurtiva typical distribution

axillae

groin

buttocks

perineal

inframammary

8
New cards

how to determine treatment for hidradenitis suppurtiva

hurley staging of severity

9
New cards

hurley stage 1

mild

recurrent abscesses without scarring or sinus tract formation (tunnels)

10
New cards

hurley stage 2

moderate

recurrent abscesses with scarring and sinus tract formation separated by normal skin

11
New cards

hurley stage 3

severe

recurrent abscesses with scarring and sinus tract formation with no intervening normal skin

12
New cards

why do GS and culture for hidradenitis suppurtiva?

if secondary infection (staph aureus) suspected

13
New cards

treatment hurley stage 1

topical clinda +

1) doxy

2) oral clinda + oral rifampin

3) spironolactone (females with comorbid pcos/premenstrual flares)

14
New cards

treatment hurley stage 2

same as hurley stage 1, plus:

1) immunosuppressives (humira, remicade)

2) other options: (dapsone, cyclosporin, acitretin)

15
New cards

treatment hurley stage 3

pharm tx for stages 1 and 2, then:

1) surgical interventions

2) pain control

16
New cards

pt's with hidradenitis suppurtiva are at an increased risk of

cardiovascular events and malignancies

17
New cards

hidradenitis suppurtiva remission is more common in

non-smokers, those who have quit smoking, non-obese individuals

18
New cards

acrochordon aka

skin tag

19
New cards

population affected by acrochordons

mid 40s-60s

weight gain

20
New cards

manifestation of acrochordons

asymptomatic, soft, flesh-colored papules on thin stalk (contains central BV)

21
New cards

acrochordon diagnosis

clinical

22
New cards

acrochordon biopsy would show

loose fibrous tissue in dermis of a polyp with thin epidermis

23
New cards

tx options for acrochordon

cryo

shave excision

scissors +/-cauterization

24
New cards

lipoma

benign localized overgrowth of fat cells under the skin (trunk, neck, arms, axillae)

25
New cards

lipoma diagnosis

clinical

26
New cards

lipoma histopathology results

well-circumscribed adipose tumor with a thin capsule

27
New cards

angiolipoma histopathology results

adipose collections containing a proliferation of capillary-sized vessels

28
New cards

epidermal inclusion cyst

benign growths of upper portion of hair follicle, capsule filled with keratin debris

29
New cards

cause of epidermal inclusion cyst

plugging of follicular openings, arise from infundibulum of hair follicle

30
New cards

epidermal inclusion cyst affect what areas (most commonly)

central trunk and face

31
New cards

hallmarks of inflamed epidermal inclusion cyst

swelling, pain, purulent drainage (cheesy, foul odor)

32
New cards

hallmarks of non-inflamed epidermal inclusion cyst

asymptomatic, central punctum (black)

33
New cards

epidermal inclusion cyst diagnosis

clinical

34
New cards

epidermal inclusion cyst biopsy results

cyst in dermis lined with stratified squamous epithelium and filled with keratin flakes

35
New cards

epidermal inclusion cyst culture of contents will be _____

sterile

36
New cards

standard of care for non-inflamed epidermal inclusion cyst

surgical removal of entire capsule

37
New cards

standard of care for inflamed epidermal inclusion cyst

38
New cards

hypertrophic scar

symptomatic scar, does not extend beyond border of original injury

39
New cards

keloid

type of hypertrophic scar that will grow beyond the borders of original injury

40
New cards

keloid biopsy results

whorls of fibroblasts, think bands collagen

(biopsy has risk of scarring!)

41
New cards

treatment of hypertrophic scars

will become more supple over the years

intralesional steroid injections

surgical correction

42
New cards

treatment of keloids

will not become more supple over the years

intralesional steroid infections

surgical correction

referral required for management

43
New cards

population affected by pilonidal disease

3:1 male: female

peak between 16-20 y/o

44
New cards

cause of pilonidal disease

hair follicles become blocked > foreign body granuloma reaction and drainage

45
New cards

manifestation of pilonidal disease

acute abscess midline in upper gluteal cleft

-+/- pain, drainage, systemic sx possible

46
New cards

pilonidal disease diagnosis

clinical

47
New cards

pilonidal disease culture

if purulence present to direct treatment

48
New cards

treatment of pilonidal disease painless cyst

monitor

49
New cards

treatment of pilonidal disease acute abscess

1) I&D

2) abx for concomitant cellulitis:

-1st gen ceph + metronidazole

3) refer to general surgery

50
New cards

post-inflammatory hyperpigmentation

acquired disorder causing darkening of the skin secondary to inflammation/trauma, epi or dermis

51
New cards

post-inflammatory hyperpigmentation diagnosis

clinical

52
New cards

post-inflammatory hyperpigmentation wood's lamp exam results

epidermal pigmentation will enhance

dermal pigmentation does not enhance

53
New cards

post-inflammatory hyperpigmentation biopsy

increase in epidermal melanin +/- dermal melanophages

54
New cards

post-inflammatory hypopigmentation

acquired disorder causing lightening of the skin secondary to inflammation/trauma, epi or dermis

55
New cards

post-inflammatory hypopigmentation wood's lamp

may be more visible but won't be as bright as other disorders

56
New cards

post-inflammatory hypopigmentation biopsy

non specific: decrease melanin in epi, decrease melanophages in upper dermis

57
New cards

melasma

acquired hypermelanosis characterized by symmetric hyperpigmented patches with irregular borders on sun exposed regions of face

58
New cards

causes of melasma

sun exposure and hormones

59
New cards

melasma dx

clinical

60
New cards

melasma biopsy (if atypical or dx uncertain)

epidermal: enlarged melanocytes

dermal: melanophages/somes in dermis, limited melanin in epidermis

61
New cards

acanthosis nigricans

cutaneous manifestation of insulin resistance (often secondary to DM)

62
New cards

manifestation of acanthosis nigricans

thick velvety brown/black plaques, symmetrical, gradual onset

("looks dirty but can't wash it off")

63
New cards

affected areas of acanthosis nigricans

neck, axillae, groin, intertriginous areas

64
New cards

acanthosis nigricans palmar involvement may be a sign of

malignancy

65
New cards

acanthosis nigricans diagnosis

clinical

66
New cards

acanthosis nigricans biopsy

hyperkeratosis with increased pigmentation of basal layers

67
New cards

acanthosis nigricans labs

to ID underlying etiology

68
New cards

treatment of acanthosis nigricans should focus on

ID and tx of underlying disease

69
New cards

manifestation of pityriasis alba

round/ovoid, scaly, hypopigmented macule/patches that fade over the course of weeks, usually asymptomatic

70
New cards

population affected by pityriasis alba

children/adolescents > adults (<12 y/o)

71
New cards

areas affected by pityriasis alba

face, neck, trunk

72
New cards

pityriasis alba diagnosis

clinical

73
New cards

pityriasis alba biopsy (if dx unclear)

decrease # active melanocytes, smaller/fever melanosomes, less melanin in basal layer

74
New cards

peak onset of vitiligo

10-20 y/o

75
New cards

manifestation of vitiligo

slow progression of white, well-circumscribed spots, smooth (most common type = generalized)

76
New cards

cause of vitiligo

CD8+ T cells destroy melanocytes > loss of pigment

77
New cards

vitiligo wood's lamp

accentuates areas of non-scaly depigmentation

78
New cards

vitiligo biopsy

absence of melanocytes

79
New cards

what are more likely to develop in areas of depigmentation

actinic keratoses and skin cancer

80
New cards

post-inflammatory hyperpigmentation conservative treatment

treat underlying cause

sun protection

81
New cards

post-inflammatory hyperpigmentation gold standard

hydroquinone (gold standard)

topical retinoids +/- low potency topical steroid

82
New cards

post-inflammatory hypopigmentation treatment

1) treat underlying inflammatory disorder

2) repigmentation from sun (caution)

83
New cards

melasma conservative treatment

sun protection

minimize exogenous hormone exposure

84
New cards

melasma 1st line treatment

topical lightening agents

-hydroquinone, topical tretinoin +/- low potency topical steroid

85
New cards

acanthosis nigricans treatment

1) treat underlying disease!

2) topical agents (retinoids, hydroxyquinone, topical steroids, etc)

86
New cards

pityriasis alba treatment

1) proper moisturization and sun protection

2) topical steroids prn

87
New cards

vitiligo pharmacological treatment options

1) topical steroids (high or super high potency)

2) topical calcineurin inhibitors

3) topical vitamin D analogs